Add to ORKGColorectal cancer is a leading cause of morbidity and mortality with about 18 000 deaths in the UK and 56 000 in the USA each year. Despite improvements in surgical technique, radiotherapy, and adjuvant chemotherapy, 50% of patients apparently 'cured' by surgery subsequently relapse and die of the disease. There is an obvious need to develop novel rational therapies based on understanding the molecular signatures that separate tumour from normal colorectal epithelium
Immunotherapy in the metastatic setting has drastically altered the landscape of treatment for vario...
A better knowledge of the complex interactions between cancer cells and the immune system has led to...
Colorectal cancer is the third most prevalent malignancy in Western countries and a major cause of d...
Colorectal cancer is a leading cause of morbidity and mortality with about 18 000 deaths in the UK a...
There have been significant improvements in the diagnosis and treatment of colorectal cancer over th...
International audienceImmunotherapy is a very promising field of research and application for treati...
Colorectal cancer (CRC) is considered the third most common cancer type and the second cause of canc...
Though early-stage colorectal cancer has a high 5 year survival rate of 65–92% depending on the spec...
Cancer immunotherapy has become an indispensable mode of treatment for a multitude of solid tumor ca...
In the last few years, significant advances in molecular biology have provided new therapeutic optio...
Advanced colorectal cancer is a common disease with an high mortality rate. For four decades, pharma...
Immunotherapy encompasses a variety of interventions and techniques with the common goal of elicitin...
Although significant therapeutic improvement has been achieved in the last 10 years, the survival of...
Although significant therapeutic improvement has been achieved in the last 10 years, the survival of...
Immunotherapy has increasingly proven to be a key treatment modality that can make a significant imp...
Immunotherapy in the metastatic setting has drastically altered the landscape of treatment for vario...
A better knowledge of the complex interactions between cancer cells and the immune system has led to...
Colorectal cancer is the third most prevalent malignancy in Western countries and a major cause of d...
Colorectal cancer is a leading cause of morbidity and mortality with about 18 000 deaths in the UK a...
There have been significant improvements in the diagnosis and treatment of colorectal cancer over th...
International audienceImmunotherapy is a very promising field of research and application for treati...
Colorectal cancer (CRC) is considered the third most common cancer type and the second cause of canc...
Though early-stage colorectal cancer has a high 5 year survival rate of 65–92% depending on the spec...
Cancer immunotherapy has become an indispensable mode of treatment for a multitude of solid tumor ca...
In the last few years, significant advances in molecular biology have provided new therapeutic optio...
Advanced colorectal cancer is a common disease with an high mortality rate. For four decades, pharma...
Immunotherapy encompasses a variety of interventions and techniques with the common goal of elicitin...
Although significant therapeutic improvement has been achieved in the last 10 years, the survival of...
Although significant therapeutic improvement has been achieved in the last 10 years, the survival of...
Immunotherapy has increasingly proven to be a key treatment modality that can make a significant imp...
Immunotherapy in the metastatic setting has drastically altered the landscape of treatment for vario...
A better knowledge of the complex interactions between cancer cells and the immune system has led to...
Colorectal cancer is the third most prevalent malignancy in Western countries and a major cause of d...